The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women
Open accessAbstract
Women with polycystic ovary syndrome (PCOS) are insulin resistant, have insulin secretory defects, and are at high risk for glucose intolerance. We performed this study to determine the prevalence of glucose intolerance and parameters associated with risk for this in PCOS women. Two-hundred and fifty-four PCOS women, aged 14-44 yr, were prospectively evaluated at 2 centers, 1 urban and ethnically diverse (n = 110) and 1 rural and ethnically homogeneous (n = 144). The rural PCOS women were compared to 80 control women of similar weight, ethnicity, and age. A 75-g oral glucose challenge was administered after a 3-day 300-g carbohydrate diet and an overnight fast with 0 and 2 h blood samples for glucose levels. Diabetes was categorized according to WHO criteria. The prevalence of glucose intolerance was 31.1% impaired glucose intolerance (IGT) and 7.5% diabetes. In nonobese PCOS women (body mass index, <27 kg/m2), 10.3% IGT and 1.5% diabetes were found. The prevalence of glucose intolerance was significantly higher in PCOS vs. control women (chi2 = 7.0; P = 0.01; odds ratio = 2.76; 95% confidence interval = 1.23-6.57). Variables most associated with postchallenge glucose levels were fasting glucose levels (P < 0.0001), PCOS status (P = 0.002), waist/hip ratio (P = 0.01), and body mass index (P = 0.021). The American Diabetes Association criteria applied to fasting glucose significantly underdiagnosed diabetes compared to the WHO criteria (3.2% vs. 7.5%; chi2 = 4.7; P = 0.046; odds ratio = 2.48; 95% confidence interval = 1.01-6.69). We conclude that 1) PCOS women are at significantly increased risk for IGT and type 2 diabetes mellitus at all weights and at a young age; 2) these prevalence rates are similar in 2 different populations of PCOS women, suggesting that PCOS may be a more important risk factor than ethnicity or race for glucose intolerance in young women; and 3) the American Diabetes Association diabetes diagnostic criteria failed to detect a significant number of PCOS women with diabetes by postchallenge glucose values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As such, women with PCOS exhibit increased risk of impaired glucose tolerance and T2DM regardless of weight and age [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“Approximately 50–70% of women with PCOS have IR and hyperinsulinaemia [128], whereas many also present evidence of glucose intolerance [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“In women with PCOS, dysglycemia typically consists of impaired glucose tolerance [12], its prevalence being of almost 30% in both adult women [13] and affected adolescents [14].”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [12]
In the citing paper
“PCOS patients commonly have metabolic complications, such as type 2 diabetes, insulin resistance (IR), and adipose tissue dysfunction (7–9).”
From Circulating Adipokine Levels in Nonobese Women with Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis (2021) · cites this paper as [7]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“In PCOS, other novel CVD risk factors, premature cardiovascular dysfunction and subclinical CVD 29,30,83 have been noted and are related to IR and obesity. 84-89”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [85]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 1,001–1,100 of 1,388
Hyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome
Rosenfield, R. L., Barnes, R. B., & Ehrmann, D. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00133-5 · Cited by 17
Statins for women with polycystic ovary syndrome not actively trying to conceive
Raval, A. D., Hunter, T., Stuckey, B. G. A., & Hart, R. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008565 · Cited by 16
Correlation of Polycystic Ovarian Syndrome Phenotypes With Pregnancy and Neonatal Outcomes
Chan, J. L., Legro, R. S., Eisenberg, E., Pisarska, M. D., & Santoro, N. F. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005702 · Cited by 17
Self-citationDerbent, A., Kargılı, A., Koca, C., Gümüş, İ. İ., Sevgili, S., Simavlı, S. A., Karakurt, F., & Turhan, N. Ö. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487612 · Cited by 16
Palomba, S., Seminara, G., Costanzi, F., Caserta, D., & Aversa, A. (2024) · Biomedicines · doi:10.3390/biomedicines12122859 · Cited by 18
Schiffer, L., Oestlund, I., Snoep, J. L., Gilligan, L. C., TAYLOR, A. E. R., Sinclair, A. J., Singhal, R., Freeman, A., Ajjan, R., Tiganescu, A., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202302131r · Cited by 14
Şahin, S. B., Durakoğlugil, T., Ayaz, T., Şahin, O. Z., Durakoğlugil, M. E., Sümer, F., Aktaş, E., & Alyildiz, N. (2015) · Endocrine Practice · doi:10.4158/ep14435.or · Cited by 15
Autonomic dysfunction in patients with polycystic ovary syndrome
Dağ, Z. Ö., Alpua, M., Türkel, Y., & Işık, Y. (2015) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2015.03.002 · Cited by 15
Koopman, R. J., Swofford, S., Beard, M. N., & Meadows, S. E. (2009) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2009.01.006 · Cited by 15
Family-based analysis of INSR polymorphisms in Chinese PCOS
Du, J., Wang, J., Sun, X., Xu, X., Zhang, F., Wang, B., Shi, Y., & Chen, Z. (2014) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2014.03.028 · Cited by 15
Update: The Pathogenesis and Treatment of PCOS
Hill, K. M. (2003) · The Nurse Practitioner · doi:10.1097/00006205-200307000-00002 · Cited by 15
Polycystic ovary syndrome and pregnancy outcome: red herring or red flag?
Siassakos, D. M., & Wardle, P. G. (2007) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2007.01418.x · Cited by 15
Polycystic Ovarian Syndrome: the Next Cardiovascular Dilemma in Women?
Srikanthan, P., Korenman, S. G., & Davis, S. S. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.05.001 · Cited by 14
Calprotectin is a potential prognostic marker for polycystic ovary syndrome
Chen, S., Jiang, M., Ding, T., Wang, J., & Long, P. (2016) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563216653762 · Cited by 15
Improving an Ovulation Rate in Women with Polycystic Ovary Syndrome by Using Silymarin
Taher, M. A., A.Atia, Y., & K.Amin, M. (2017) · Iraqi Journal of Pharmaceutical Sciences · doi:10.31351/vol19iss2pp11-18 · Cited by 15
Female-Specific Factors for IHD: Across the Reproductive Lifespan
SHUFELT, C. L., Waldman, T., Wang, E. T., & Merz, C. N. B. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0481-6 · Cited by 15
Recent advances in the treatment of polycystic ovary syndrome
Yıldız, B. O. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.10.1295 · Cited by 16
The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome
Trakakis, E., Basios, G., Peppa, Μ., Simeonidis, G., Labos, G., Creatsa, M. G., Misailidou, M., Boutati, E. I., Vaggopoulos, V., Παναγόπουλος, Π., et al. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.683058 · Cited by 15
Azeemuddin, M. M., Anturlikar, S. D., Mallappa, O., Baig, M. R., Ashok, B. K., Rao, R. P., Rafiq, M., & Paramesh, R. (2019) · Advances in Pharmacological Sciences · doi:10.1155/2019/8272850 · Cited by 16
Midlife women’s health consequences associated with polycystic ovary syndrome
Ali, A. T., & Guidozzi, F. (2019) · Climacteric · doi:10.1080/13697137.2019.1679111 · Cited by 16
Polycystic ovary syndrome and abnormalities in glucose tolerance
Bhattacharya, S. M. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2008.11.031 · Cited by 15
INSULIN RESISTANCE AND POLYCYSTIC OVARY SYNDROME IN A CHINESE POPULATION
Chen, C., Jing, G., Zhou, L., Juan, S., Bin, C., & Jie, H. (2017) · Endocrine Practice · doi:10.4158/ep171849.or · Cited by 15
Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome
Armeni, E., & Lambrinoudaki, I. V. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666180828154006 · Cited by 15
Inter- and intrafamilial variability in premature pubarche and polycystic ovary syndrome
Sanders, E. B., Aston, C. E., Ferrell, R. E., & Witchel, S. F. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03252-1 · Cited by 15
Witchel, S. F., Trivedi, R. N., & Kammerer, C. M. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00506-5 · Cited by 15
Homa, L. D., Burger, L. L., Cuttitta, A. J., Michele, D. E., & Moenter, S. M. (2015) · Endocrinology · doi:10.1210/en.2015-1593 · Cited by 15
Mott, M. M., Kitos, N. R., & Coviello, A. D. (2014) · Endocrine Practice · doi:10.4158/ep13414.or · Cited by 14
Women With Polycystic Ovary Syndrome Have Comparable Hip Bone Geometry to Age-Matched Control Women
McBreairty, L. E., Zello, G. A., Gordon, J. J., Serrao, S. B., Pierson, R. A., Chizen, D. R., & Chilibeck, P. D. (2016) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2016.10.007 · Cited by 14
Changes in Metabolic Profile in the Women with a History of PCOS—A Long-Term Follow-Up Study
Jacewicz‐Święcka, M., & Kowalska, I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103367 · Cited by 14
Interventional Studies for Polycystic Ovarian Syndrome in Children and Adolescents
Vuguin, P. M. (2010) · Pediatric Health · doi:10.2217/phe.09.69 · Cited by 14
Anormalidades metabólicas em mulheres com síndrome dos ovários policísticos: obesas e não obesas
Romano, L. G. M., Bedoschi, G., de Melo, A. S., de Albuquerque, F. O., Silva, A. C. J. D. S. R. E., Ferriani, R. A., & Navarro, P. A. (2011) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032011000600008 · Cited by 14
Seow, K., Tsai, Y.-L., Juan, C., Lin, Y., Hwang, J., & Ho, L. (2009) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2009.05.003 · Cited by 14
Management of Pediatric and Adolescent Type 2 Diabetes
Samaan, M. C. (2013) · International Journal of Pediatrics · doi:10.1155/2013/972034 · Cited by 16
Premature Aging of Cardiovascular/Platelet Function in Polycystic Ovarian Syndrome
Chan, W. P. A., Ngo, D. T. M., Sverdlov, A. L., Rajendran, S., Stafford, I., Heresztyn, T., Chirkov, Y. Y., & Horowitz, J. D. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.12.015 · Cited by 14
Gourgari, E., Spanakis, E. K., & Dobs, A. S. (2016) · International Journal of Women s Health · doi:10.2147/ijwh.s104825 · Cited by 14
Giandalia, A., Pappalardo, M. A., Russo, G. T., Romeo, E. L., Alibrandi, A., Bari, F. D., Vita, R., Cucinotta, D., & Benvenga, S. (2018) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2018.05.002 · Cited by 14
El-Kannishy, G. M., Kamal, S., Mousa, A. A., Saleh, O., Badrawy, A. E., El-Farahaty, R. M., & Shokeir, T. A. (2009) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2009.08.001 · Cited by 13
RetractedΜacut, D., Micić, D., Parapid, B. J., et al. (2002) · Vojnosanitetski pregled · doi:10.2298/vsp0206593m · Cited by 14
Comparison of metformin and thiazolidinediones in the management of polycystic ovary syndrome
Baillargeon, J., Iuorno, M. J., & Nestler, J. E. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200208000-00003 · Cited by 14
Pazderska, A., Tun, T. K., Phelan, N., McGowan, A., Sherlock, M., Behan, L., Boran, G. P., & Gibney, J. (2017) · Clinical Endocrinology · doi:10.1111/cen.13542 · Cited by 17
Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome
(2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.004 · Cited by 14
Hepatokines: the missing link in the development of insulin resistance and hyperandrogenism in PCOS?
Stefanaki, K., Ilias, Ι., Paschou, S. Α., & Karagiannakis, D. S. (2023) · HORMONES · doi:10.1007/s42000-023-00487-x · Cited by 15
Maharaj, S., & Amod, A. (2009) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2009.10872199 · Cited by 14
Noguchi, H., Iwasa, T., Iwase, A., Kanasaki, H., Kimura, F., Kugu, K., Saito, K., Baba, T., Hara, T., & Matsuzaki, T. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15972 · Cited by 13
Abu‐Zaid, A., Baradwan, S., Alyafi, M., Baalharith, M. A., Alsehaimi, S. O., Alsabban, M., Alsharif, S. A., Alqarni, S. M. S., Albelwi, H., Jamjoom, M. Z., et al. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.06.031 · Cited by 13
Kiconco, S., Tay, C. T., Rassie, K. L., Azziz, R., Teede, H. J., & Joham, A. E. (2022) · Human Reproduction · doi:10.1093/humrep/deac077 · Cited by 13
Faubert, J., Battista, M., & Baillargeon, J. (2016) · Journal of Animal Science · doi:10.2527/jas.2015-0089 · Cited by 12
Polycystic Ovary Syndrome: Correlation between Phenotypes and Metabolic Syndrome
Maciel, G. A. R. (2013) · Journal of Steroids & Hormonal Science · doi:10.4172/2157-7536.1000132 · Cited by 13
Crisosto, N., Flores, C., Maliqueo, M. A., Echiburú, B., Vásquez, J., Maluenda, F., & Sir‐Petermann, T. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.051 · Cited by 13
The Role of Androgen Excess in Metabolic Dysfunction in Women
Escobar-Morreale, H. F. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_26 · Cited by 13
Sankarganesh, D., Suriyakalaa, U., Ramachandran, R., et al. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.02.009 · Cited by 13
Polycystic ovarian syndrome: a misnomer for an enigmatic disease
Lam, P. M., & Raine‐Fenning, N. J. (2009) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.6414 · Cited by 12
Risk factors for glucose intolerance in Danish women with polycystic ovary syndrome
Trolle, B., & Lauszus, F. F. (2005) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.0001-6349.2005.00627.x · Cited by 15
Insulin Resistance in Polycystic Ovarian Disease
Bhatia, V. (2005) · Southern Medical Journal · doi:10.1097/01.smj.0000177251.15366.85 · Cited by 13
Lenarcik, A., Łaczmański, Ł., Milewicz, A., Bidzińska−Speichert, B., Pawlak, M., Kolačkov, K., Kuliczkowska-Płaksej, J., Trzmiel-Bira, A., & Brona, A. (2014) · Endokrynologia Polska · doi:10.5603/ep.2014.0025 · Cited by 12
Yang, Y., Ding, M., Di, N., Azziz, R., Yang, D., & Zhao, X. (2018) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22699 · Cited by 12
Polycystic Ovary Syndrome: A Brief Review with Recent Updates
Shermin, S., Noor, A., & Jahan, S. (2020) · Delta Medical College Journal · doi:10.3329/dmcj.v7i2.45567 · Cited by 14
Karakaya, C., Çil, A. P., Bilgüvar, K., Çakır, T., Karalök, M. H., Karabacak, O., & Çağlayan, A. O. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15187 · Cited by 13
Panidis, D., Τζιόμαλος, Κ., Papadakis, E. P., Kandaraki, E., & Katsikis, I. (2013) · HORMONES · doi:10.14310/horm.2002.1403 · Cited by 12
Gunning, M. N., van Rijn, B. B., Bekker, M. N., de Wilde, M. A., Eijkemans, M. J. C., & Fauser, B. C. J. M. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1563885 · Cited by 12
Assessing the risk of impaired glucose metabolism in overweight adolescents in a clinical setting
Velasquez‐Mieyer, P., Cowan, P. A., Neira, C. P., & Tylavsky, F. A. (2008) · The journal of nutrition health & aging · doi:10.1007/bf03028625 · Cited by 11
Deciphering the cis-regulatory elements of co-expressed genes in PCOS by in silico analysis
Sarkar, C., & Maitra, A. (2007) · Gene · doi:10.1016/j.gene.2007.10.026 · Cited by 13
Abnormal glucose tolerance in polycystic ovary syndrome
Bhattacharya, S. M. (2007) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2007.00690.x · Cited by 12
Pérez‐Bravo, F., Echiburú, B., Maliqueo, M. A., Santos, J. L., & Sir‐Petermann, T. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02183.x · Cited by 12
Long-term health consequences of polycystic ovary syndrome
Κousta, E., & Franks, S. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545191.007 · Cited by 11
Polycystic ovary syndrome: the new millenium
Legro, R. S. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00033-3 · Cited by 12
Self-citationChinese herbal medicine for subfertile women with polycystic ovarian syndrome
Zhang, J., Zhou, L., Tang, L., Wu, T., & Lim, D. C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007535 · Cited by 11
Abdel-Rahman, M., Jackson, L. W., Rodewald, K. J., Abdellah, M. A., Ismail, S. A., & Hurd, W. W. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.03.007 · Cited by 11
Hyperandrogenemia is Common in Asymptomatic Women and is Associated with Increased Metabolic Risk
Torchen, L. C., Tsai, J. N., Jasti, P., Macaya, R., Sisk, R. K., Dapas, M., Hayes, M. G., Urbanek, M., & Dunaif, A. E. (2019) · Obesity · doi:10.1002/oby.22659 · Cited by 12
Gümüş, Ü., Güzel, A. İ., Topçu, H. O., Tımur, H., Yılmaz, N., & Danışman, N. (2014) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2014.08.007 · Cited by 11
Walch, K., Grimm, C., Huber, J. C., et al. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.07.002 · Cited by 11
Pelletier, L., & Baillargeon, J. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.02.047 · Cited by 10
Seow, K., Lin, Y., Hwang, J., Wang, P.-Y., Ho, L. ‐., Lin, Y., & Juan, C. (2010) · Human Reproduction · doi:10.1093/humrep/deq351 · Cited by 11
Missel, A. L., O’Brien, A., MASER, H., Kanwal, A., Bayandorian, H., Martin, S., Carrigan, P., McNamee, R., Daubenmier, J. J., Isaman, D. J. M., et al. (2021) · F&S Reports · doi:10.1016/j.xfre.2021.08.008 · Cited by 12
Increased secretion of amylin in women with polycystic ovary syndrome
James, S., Moralez, J., & Nagamani, M. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.02.086 · Cited by 11
Peng, C., Guo, Z., Long, X., & Lu, G. (2012) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-012-9762-6 · Cited by 11
Wang, K., Li, Y., Shi, Y., Wang, L., Zhang, M., & Chen, Z. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.06.016 · Cited by 11
Priorities in polycystic ovary syndrome
Løbo, R. A. (2001) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2001.tb143431.x · Cited by 11
The Insulin Resistance of Polycystic Ovary Syndrome
Demissie, M., Legro, R. S., & Dunaif, A. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_26 · Cited by 11
Self-citationScannell, N., Villani, A., Moran, L., & Mantzioris, E. (2025) · Proceedings of the Nutrition Society · doi:10.1017/s0029665124007584 · Cited by 12
“Similar improvements in metabolic risk profiles have also been observed in people with existing T2DM.”
InfluentialVural, P., Kiraz, Z. K., Doğru‐Abbasoğlu, S., Çil, E., Karadağ, B., & Uysal, M. (2010) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2010.00915.x · Cited by 10
Tang, S., Wang, C., Tang, H., et al. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1830-6 · Cited by 10
Role of Lifestyle and Diet in the Management of Polycystic Ovarian Syndrome
Krystock, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_9 · Cited by 11
Arjmand, A. T., Nouri, M., & Tavakolian Arjmand, S. (2015) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2015.08.007 · Cited by 10
Depression and Insulin Resistance: Applications to Polycystic Ovary Syndrome
Brown, A. J. (2004) · Clinical Obstetrics & Gynecology · doi:10.1097/01.mog.0000126135.73066.89 · Cited by 10
Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome
Paterakis, T., & Diamanti‐Kandarakis, E. (2014) · Current Obesity Reports · doi:10.1007/s13679-014-0127-6 · Cited by 10
Le syndrome des ovaires polykystiques (SOPK)
Torre, A., & Fernandez, H. (2007) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2007.04.002 · Cited by 11
Raja-Khan, N. T., Shuja, S. A., Kunselman, A. R., et al. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.10.027 · Cited by 10
Self-citationAlves, M. M. C., Almeida, M., Oliani, A. H., Breitenfeld, L., & Ramalhinho, A. C. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.06.010 · Cited by 10
Manti, M., Pui, H., Edström, S., Risal, S., Lu, H., Lindgren, E., Ohlsson, C., Jerlhag, E., Benrick, A., Deng, Q., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001060r · Cited by 10
Doll, I., Doll, R., & Bühling, K. J. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-2014-7 · Cited by 10
Caracterización clínica y bioquímica de la mujer con Síndrome de Ovario Poliquístico
Builes, C. A., Díaz, I., Castañeda, J., & Pérez, L. E. (2006) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.534 · Cited by 10
Low fertility and the risk of type 2 diabetes in women
Elbers, C. C., Onland‐Moret, N. C., Eijkemans, M. J. C., Wijmenga, C., Grobbee, D. E., & van der Schouw, Y. T. (2011) · Human Reproduction · doi:10.1093/humrep/der332 · Cited by 10
Insulin resistance: what is its role in the polycystic ovary syndrome?
Moghetti, P. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200212000-00002 · Cited by 10
The cause of the epidemic of type 2 diabetes in children
Rosenbloom, A. L. (2000) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200008000-00003 · Cited by 10
Efficacy of Spironolactone in Adult Acne in Polycystic Ovary Syndrome Patients an Original Research
Rani, N., Kumar, P., Mishra, A. K., et al. (2021) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_391_21 · Cited by 9
Haller, K., Laisk, T., Peters, M., Talving, E., Karits, P., Karro, H., Uibo, R., & Salumets, A. (2007) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340701322085 · Cited by 9
Davis, S., Hendryx, J., Bouwer, S., Menezes, C., Menezes, H., Patel, V., & Speelman, D. L. (2019) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2019.004 · Cited by 9
Singh, N. J., Hutson, R., Milton, N. G. N., & Javid, F. A. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174752 · Cited by 9
Investigation of Prevalence and Awareness of Polycystic Ovary Syndrome among Pakistani Females
Zulfiqar, S., Tahir, S., Gulraiz, S., Razzaq, M. A., Abid, A., Shahid, T., Babar, A., Rehman, B., Rafique, H., Noor, S., et al. (2022) · Proceedings of the Pakistan Academy of Sciences B Life and Environmental Sciences · doi:10.53560/ppasb(59-1)703 · Cited by 9
Metadata
- Authors
- Legro, R. S.
- Affiliations
- Pennsylvania State University (US)
- ORCID
- Legro, R. S.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-01-01
- Volume
- 84
- Issue
- 1
- Pages
- 165-169
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2096126402
- Cited by
- 1,743
- References
- 0
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 36 · 2023: 24 · 2022: 50 · 2021: 64 · 2020: 54 · 2019: 42 · 2018: 43 · 2017: 66 · 2016: 59 · 2015: 88 · 2014: 81 · 2013: 73 · 2012: 84
- FWCI
- 44.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K08 HD-O118, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, type 2 diabetes, impaired glucose tolerance, insulin resistance, insulin secretion, diabetes risk factors, prevalence, fasting blood glucose, waist-to-hip ratio, body mass index, ethnic differences, diagnostic criteria, underdiagnosis, oral glucose tolerance test, young women, obesity
- MeSH terms
- Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Prospective Studies, Risk, Body Mass Index, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
